Consensus and disputes on the adjuvant therapy for non-small cell lung cancer with positive surgical margins / 中华放射肿瘤学杂志

ABSTRACT

For non-small cell lung cancer (NSCLC) patients with positive surgical margins, the survival rates can be dramatically decreased. However, high-level evidence is lacking in the standard adjuvant treatment for NSCLC patients with positive surgical margins. In this article, consensus and disputes on the adjuvant therapy for NSCLC patients with positive surgical margins were reviewed.